Eurofins Expands Its Footprint in the Balkan Region with the Acquisition of Environmental Research & Industrial Co-Operation ...
June 23 2017 - 1:15AM
Business Wire
Regulatory News:
Eurofins Scientific (Paris:ERF) (EUFI.PA), the global leader in
environment testing, announces that it has signed an agreement to
acquire Environmental Research & Industrial Co-operation
(“ERICo”), the leading independent laboratory for environment
testing services in Slovenia.
As the largest private environment testing laboratory in the
country, ERICo provides a comprehensive portfolio of analytical
services for water, air and soil testing. The company also provides
research and consultancy as part of its analytical service
offering. Founded 25 years ago, the company employs 46 staff at its
laboratory in Velenje, northeast Slovenia, and serves primarily the
largest industrial companies including power plants and coal mines,
as well as public municipalities. In addition, ERICo has GMP
capabilities for pharmaceutical products testing, although this
represents a small portion of its business at present.
This acquisition therefore represents a solid entry platform, on
which Eurofins can deploy its full range of capabilities, rapidly
increase penetration and gain market share in Slovenia.
Furthermore, with a modestly growing economy1, Slovenia represents
good growth opportunities in the medium term as outsourcing to
private independent laboratories should also continue to
ramp-up.
Comment from Marijan Penšek, Senior Vice President,
Gorenje Group: “We believe ERICo will benefit from becoming part of
the Eurofins Group, and getting access to its wide range of
technical expertise and its network capabilities. We look forward
to continued collaboration between Eurofins and ERICo’s former
shareholders, the Gorenje Group (the largest hardline manufacturing
company in the country), Termoelektrarna Šoštanj (a regional power
plant) and Premogovnik Velenje (a regional coal mine).”
Comment from Dr. Gilles Martin, Eurofins’ CEO: “ERICo
provides Eurofins a good entry into the analytical testing market
in Slovenia and reinforces our footprint in central and eastern
Europe. We are looking forward to contributing to, and
strengthening ERICo’s position in its market, as well as expanding
the portfolio of tests it offers to customers by offering the full
range of services and capabilities of the Group.”
For more information, please visit
www.eurofins.com
Notes for the editor:
Eurofins – a global leader in bio-analysis
Eurofins Scientific through its subsidiaries (hereinafter
sometimes “Eurofins” or “the Group”) believes it is the world
leader in food, environment and pharmaceutical products testing and
that it is also one of the global independent market leaders in
certain testing and laboratory services for agroscience, genomics,
discovery pharmacology and for supporting clinical studies. In
addition, Eurofins is one of the key emerging players in specialty
clinical diagnostic testing in Europe and the USA. With over 28,000
staff in 310 laboratories across 39 countries, Eurofins offers a
portfolio of over 130,000 analytical methods for evaluating the
safety, identity, composition, authenticity, origin and purity of
biological substances and products, as well as for innovative
clinical diagnostic. The Group objective is to provide its
customers with high-quality services, accurate results on time and
expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities around the
world.
The shares of Eurofins Scientific are listed on the Euronext
Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg
ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgement
of Eurofins Scientific’ management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the
information available to the Company’s management as of the date of
publication, but no guarantee can be made as to their validity.
1
http://www.imf.org/external/datamapper/NGDP_RPCH@WEO/OEMDC/ADVEC/WEOWORLD/SVN
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170622005734/en/
Eurofins ScientificInvestor RelationsPhone: +32 2 766
1620E-mail: ir@eurofins.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Apr 2023 to Apr 2024